Teleflex Incorporated  

(Public, NYSE:TFX)   Watch this stock  
Find more results for TFX
267.71
+1.15 (0.43%)
Nov 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 264.45 - 268.33
52 week 142.97 - 269.78
Open 266.95
Vol / Avg. 55,306.00/252,412.00
Mkt cap 12.11B
P/E 48.36
Div/yield 0.34/0.51
EPS 5.54
Shares 45.05M
Beta 1.05
Inst. own 92%
Feb 21, 2018
Q4 2017 Teleflex Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 28, 2017
Teleflex Inc at Piper Jaffray Healthcare Conference - 11:30AM EST - Add to calendar
Nov 2, 2017
Q3 2017 Teleflex Inc Earnings Release
Nov 2, 2017
Q3 2017 Teleflex Inc Earnings Call - Webcast
Sep 12, 2017
Teleflex Inc at Morgan Stanley Healthcare Conference - Webcast
Sep 5, 2017
Teleflex Inc to Acquire Neotract Inc Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '17) 2016
Net profit margin 14.85% 12.72%
Operating margin 20.64% 16.07%
EBITD margin - 26.35%
Return on average assets 5.81% 6.12%
Return on average equity 13.18% 11.43%
Employees 12,600 -
CDP Score - -

Address

550 E Swedesford Rd Ste 400
WAYNE, PA 19087-1601
United States - Map
+1-610-2256800 (Phone)
+1-610-9485101 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company's products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products, which are offered under Hudson RCI brand. As of December 31, 2016, it manufactured its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Its all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment.

Officers and directors

Benson F. Smith Non-Executive Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Liam J. Kelly President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Thomas E. Powell Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Thomas Anthony Kennedy Senior Vice President - Global Operations
Age: 54
Bio & Compensation  - Reuters
John R. Deren Chief Accounting Officer, Vice President
Bio & Compensation  - Reuters
James J. Leyden Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Karen T. Boylan Vice President - Global RA/QA
Age: 45
Bio & Compensation  - Reuters
Cameron P. Hicks Vice President - Global Human Resources
Age: 52
Bio & Compensation  - Reuters
Gretchen R. Haggerty Director
Age: 61
Bio & Compensation  - Reuters
George Babich Jr. Independent Director
Age: 65
Bio & Compensation  - Reuters